| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2002 | US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 02/07/2002 | US20020016360 Method of diminishing the adverse effects of interleukin-2 |
| 02/07/2002 | US20020016359 Compositions and methods of treating neurodegenerative diseases |
| 02/07/2002 | US20020016357 Novel discalamide compounds and their use as anti-proliferative agents |
| 02/07/2002 | US20020016356 Antitumor agents |
| 02/07/2002 | US20020016354 Treatment of respiratory diseases, convulsions, vascular disorders, renal disorders, urinary disorders, Alzheimer's disease, dysmenorrhea, narcolepsy |
| 02/07/2002 | US20020016353 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 02/07/2002 | US20020016352 Cancer treatment with Go6976 and its related compounds |
| 02/07/2002 | US20020016348 Administering 5HT1B/1D agonist and COX-2 selective inhibitor |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016346 Administration directly to eye of compounds that inhibit function of a Na+- K+-2Cl-2 cotransporter mechanism discovered in trabecular meshwork cells of mammalian eyes |
| 02/07/2002 | US20020016344 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 02/07/2002 | US20020016343 Selective cyclooxygenase-2 inhibitor, useful in treatment of inflammation, pain and fever |
| 02/07/2002 | US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/07/2002 | US20020016341 Heterocyclic thioester and ketone hair growth compositions and uses |
| 02/07/2002 | US20020016340 Compositions and methods for treating cataracts |
| 02/07/2002 | US20020016339 Anticoagulants |
| 02/07/2002 | US20020016338 Levobupivacaine and its use |
| 02/07/2002 | US20020016337 Heterocyclic analgesic compounds and methods of use thereof |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/07/2002 | US20020016335 Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy |
| 02/07/2002 | US20020016334 Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
| 02/07/2002 | US20020016332 Method for the treatment of dermal lesions caused by envenomation |
| 02/07/2002 | US20020016331 Method of treating pain using nalbuphine and opioid antagonists |
| 02/07/2002 | US20020016330 Nonphytotoxic |
| 02/07/2002 | US20020016329 Inhibit p34cdc2/cyclin Bcdc13 kinase and protein tyrosine kinase pp60c-src and can be used for treatment of hyperproliferative diseases, for example chemotherapy of tumours or osteoporosis. |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020016327 Compounds and methods of use for treatment of neurogenic inflammation |
| 02/07/2002 | US20020016325 New drug combinations |
| 02/07/2002 | US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | US20020016318 Methods of treating breast disorders |
| 02/07/2002 | US20020016317 From ester interchange of monounsaturated fatty acid esters with sterols; food additives |
| 02/07/2002 | US20020016315 Metered unit dose comprising 40 mu g or less of budesonide is disclosed as well as a formulation thereof and the use for the treatment of conditions in the nose, especially rhinitis. |
| 02/07/2002 | US20020016314 Especially with eicosapentaenoic acid, docosapentaenoic acid, linoleic acid, linolenic acid or arachidonic acid; margarine, shortening, mayonnaise, vegetable oil, ice cream, milk or yogurt containing ester |
| 02/07/2002 | US20020016313 Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis |
| 02/07/2002 | US20020016312 Methods and compositions for the rapid and enduring relief of inadequate myocardial function |
| 02/07/2002 | US20020016311 Nitrate esters and their use for neurological conditions |
| 02/07/2002 | US20020016310 Cosmetic and pharmaceutical preparations containing photostable UV filters |
| 02/07/2002 | US20020016309 Imidazopyridine and imidazopyrimidine antiviral agents |
| 02/07/2002 | US20020016308 Complete inhibition of the platelet aggregation upon collagen in flowing blood |
| 02/07/2002 | US20020016307 Pharmaceutical composition with both a lipase inhibitor and a lipophilic polysaccharide and an improved method for treating adiposity |
| 02/07/2002 | US20020016306 Coupling arrays of metal, alloy, semiconductor or magnetic clusters scaffold comprising, for example, polynucleotides and/or polypeptides |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
| 02/07/2002 | US20020016302 Idarubicin with encapsulation degree higher than 94%. |
| 02/07/2002 | US20020016301 Preventing or treating emesis associated with a macrolide antibiotic comprising administering a Substance P antagonist, such as (2S,3S)-3-(5-tert-butyl-2-methoxybenzyl)amino-2-(3 -trifluromethoxylphenyl)piperidine |
| 02/07/2002 | US20020016299 Containing glycerolipid and/or glyceroglycolipid as effective component(s). |
| 02/07/2002 | US20020016294 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 02/07/2002 | US20020016293 Flavopiridol drug combinations and methods with reduced side effects |
| 02/07/2002 | US20020016287 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide |
| 02/07/2002 | US20020016283 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist |
| 02/07/2002 | US20020015990 Nutrient broth for use in the propagation of preferential microorgansim and generation of foods |
| 02/07/2002 | US20020015984 Methods for ansamitocin production |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015946 Antiviral polymers comprising acid functional groups and hydrophobic groups |
| 02/07/2002 | US20020015771 Dietetics |
| 02/07/2002 | US20020015762 Vitamin containing product |
| 02/07/2002 | US20020015744 Dietetic supplements; cognition activators |
| 02/07/2002 | US20020015741 Method and composition for the accelerated in vivo removal of ethanol |
| 02/07/2002 | US20020015740 Administering nitrogen oxide mimetic |
| 02/07/2002 | US20020015736 Anti-inflammatory pharmaceutical formulations |
| 02/07/2002 | US20020015735 Oral administering |
| 02/07/2002 | US20020015733 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 02/07/2002 | US20020015732 Formulation of a 5 alpha reductase inhibitor for oral administrtion, and a preparation process and use thereof |
| 02/07/2002 | US20020015729 Colonic delivery of weak acid drugs |
| 02/07/2002 | US20020015728 Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 02/07/2002 | US20020015722 Food product |
| 02/07/2002 | US20020015721 Dispersion containing nonionic surfactants |
| 02/07/2002 | US20020015718 Use of physiologically compatible sulfinic acids as antioxidant or free-radical scavenger in cosmetic or dermatological preparations |
| 02/07/2002 | US20020015717 Skin care cosmetic compositions containing carboxymethylates of branched alcohols and/or ethoxylates thereof |
| 02/07/2002 | US20020015715 Inducing interferon and tumor necrosis factor locally in the skin or mucous memebranes by applying 4-amino-2-ethoxymethyl-alpha,alpha-di methyl-1H-imidazo(4,5-c)quinoline-1-ethanol, silica sol, triacetin and propylene glycol |
| 02/07/2002 | US20020015713 An amine containing compound such as the antidepressant dioxepin or the muscle relaxant guaifenesin and carriers |
| 02/07/2002 | US20020015690 A compound, comprising a molecularly imprinted polymer featuring at least one functional monomer selected from the vinyl hydroxypyridine; monomers selected from 4-vinylbenzamide and N-alkyl or N,N-dialkyl derivatives |
| 02/07/2002 | US20020015687 Method for the anhydrous loading of nicotine onto ion exchange resins |
| 02/07/2002 | US20020015686 Mono and dialkyl quats with silicone in conditioning compositions |
| 02/07/2002 | US20020015681 Comprise a first and a second copolymer of polysiloxane and an vinyl monomer, having defined molecular weights, and present in a specific ratio to each other, impart a dichotomous viscosity behavior to the hair spray |
| 02/07/2002 | US20020014242 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 02/07/2002 | US20020014111 Single riser/single capillary blood viscometer using mass detection or column height detection |
| 02/07/2002 | DE10123447A1 Cilansetron enthaltende Arzneimittel zur Behandlung nicht-obstipativer männlicher IBS-Patienten Cilansetron containing medicines for the treatment of non-obstipative male IBS patients |
| 02/07/2002 | DE10037310A1 Neue Indolderivate und deren Verwendung als Arzneimittel Novel indole derivatives and their use as medicaments |
| 02/07/2002 | DE10037146A1 Acetamidderivate Acetamide derivatives |
| 02/07/2002 | DE10036852A1 Urethanderivate Urethane |
| 02/07/2002 | DE10036818A1 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten New N-triazolylmethyl piperazine derivatives as neurokinin receptor antagonists |
| 02/07/2002 | DE10036799A1 Neues Mittel zur Behandlung der Haare und der Kopfhaut New agents for the treatment of hair and of the scalp |
| 02/07/2002 | DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives |
| 02/07/2002 | DE10036051A1 Cosmetic or dermatological preparations for treating sun-tanning contain chitosan and lecithin to delay vaporization of volatile components |
| 02/07/2002 | DE10035997A1 Verwendung von anellierten Dihydropyridinen zur Herstellung von Mitteln für die Behandlung von chronischen Schmerzen Use of fused dihydropyridines for producing agents for the treatment of chronic pain |
| 02/07/2002 | DE10035620A1 Intraokulare Infusionslösung The intraocular infusion solution |
| 02/07/2002 | DE10035156A1 New protein complex containing complex protein from botulinum toxin, useful for oral delivery of therapeutic polypeptide or low molecular weight pharmaceutical |
| 02/07/2002 | DE10035088A1 Vitamin-C-Präparat und Verfahren zu dessen Herstellung Vitamin C preparation and process for its preparation |
| 02/07/2002 | DE10032877A1 Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier III Anthelmintics for the prevention of parasitic infections in humans and animals III |
| 02/07/2002 | DE10031391A1 Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie Bicyclic compounds and their use for the prophylaxis and therapy of cerebral ischemia |
| 02/07/2002 | DE10005853C1 Verfahren zur Herstellung von Bis-(4-amino-1-pyridinium)-alkanen Alkanes process for the preparation of bis (4-amino-1-pyridinium) |
| 02/07/2002 | CA2455170A1 Charged phospholipid compositions and methods for their use |
| 02/07/2002 | CA2426297A1 Agonist of follicle stimulating hormone activity |
| 02/07/2002 | CA2425889A1 Agonists of follicle stimulating hormone activity |
| 02/07/2002 | CA2419206A1 Highly purified simvastatin compositions |
| 02/07/2002 | CA2418121A1 Antimicrobial biaryl compounds |
| 02/07/2002 | CA2418115A1 Imidazole derivatives |
| 02/07/2002 | CA2418107A1 Method for reducing or eliminating smoking |